Brief: Aeterna Zentaris Announces Last Patient Last Visit In Pivotal Detect-Trial For The Diagnosis Of Childhood-Onset Growth Hormone Deficiency
13/06/2024 14:28
June 13 (Reuters) - Aeterna Zentaris Inc AEZS.TO :
* AETERNA ZENTARIS ANNOUNCES LAST PATIENT LAST VISIT IN
PIVOTAL
DETECT-TRIAL FOR THE DIAGNOSIS OF CHILDHOOD-ONSET GROWTH HORMONE
DEFICIENCY
Source text for Eikon: ID:nGNX47r4K7
Further company coverage: AEZS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on COSCIENS Biopharma
See all newsBrief: COSCIENS Acquires Nualtis Corp
Refile: Canada's COSCIENS Biopharma Q2 net loss narrows on higher sales
Canada's COSCIENS Biopharma Q1 net income turns positive on discontinued German operations
Brief: Cosciens Biopharma Inc Not Aware Of Material Undisclosed Information Amid Recent Trading Activity
Brief: Cosciens Provides Strategic Update